Janda Kim 4
4 · Sorrento Therapeutics, Inc. · Filed Apr 15, 2021
Insider Transaction Report
Form 4
Janda Kim
Director
Transactions
- Exercise/Conversion
Common Stock
2021-04-12$3.50/sh+1,900$6,650→ 4,900 total - Exercise/Conversion
Non-qualified stock option
2021-04-12−1,900→ 0 totalExercise: $3.50From: 2012-04-15Exp: 2021-04-15→ Common Stock (1,900 underlying) - Sale
Common Stock
2021-04-12$6.97/sh−1,900$13,251→ 3,000 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 22, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.84 to $7.29, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.